Agios Pharma (AGIO) Misses Q3 EPS by 3c

Agios Pharma (NASDAQ: AGIO) reported Q3 EPS of ($1.63), $0.03 worse than the analyst estimate of ($1.60). Revenue for the quarter came in at $15.2 million versus the consensus estimate of $20.08 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
• Worthington Industries (WOR) Tops Q1 EPS by 7c
• Societe Generale SA (GLE:FP) (SCGLY) PT Raised to EUR83 at JPMorgan